Preliminary results on 225Ac-DOTATATE Targeted Alpha Therapy in Metastatic Gastroenteropancreatic Neuroendocrine Tumors: First Clinical Experience on Safety and Efficacy

被引:0
|
作者
Ballal, S. [1 ]
Yadav, M. P. [1 ]
Bal, C. [1 ]
机构
[1] All India Inst Med Sci, New Delhi, India
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-761
引用
收藏
页码:S288 / S288
页数:1
相关论文
共 50 条
  • [31] Dose escalation study of targeted alpha therapy with [225Ac]Ac-DOTA-substance P in recurrence glioblastoma – safety and efficacy
    Leszek Królicki
    Frank Bruchertseifer
    Jolanta Kunikowska
    Henryk Koziara
    Dariusz Pawlak
    Radosław Kuliński
    Rafał Rola
    Adrian Merlo
    Alfred Morgenstern
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 3595 - 3605
  • [32] Dose escalation study of targeted alpha therapy with [225Ac]Ac-DOTA-substance P in recurrence glioblastoma - safety and efficacy
    Krolicki, Leszek
    Bruchertseifer, Frank
    Kunikowska, Jolanta
    Koziara, Henryk
    Pawlak, Dariusz
    Kulinski, Radoslaw
    Rola, Rafal
    Merlo, Adrian
    Morgenstern, Alfred
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (11) : 3595 - 3605
  • [33] [225Ac]Ac-PSMA-617 Targeted Alpha Therapy in Metastatic Castration-Resistant Prostate Cancer: efficacy and treatment outcome
    Ebrahimifard, A.
    Bagheri, S.
    Wang, Q.
    Eilsberger, F.
    Luster, M.
    Librizzi, D.
    Yousefi, B. H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S360 - S360
  • [34] Efficacy and Safety of 225Ac-PSMA-617-Targeted Alpha Therapy in Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
    Ma, Jiao
    Li, Lanying
    Liao, Taiping
    Gong, Weidong
    Zhang, Chunyin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [35] Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients Receiving Concomitant 225Ac-DOTATATE-Targeted a-Therapy and Capecitabine: A Real-World-Scenario Management-Based Long-Term Outcome Study
    Ballal, Sanjana
    Yadav, Madhav P.
    Tripathi, Madhavi
    Sahoo, Ranjit Kumar
    Bal, Chandrasekhar
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (02) : 211 - 218
  • [36] Labeling process and quality control results of 225Ac-PSMA-617 for targeted alpha particle therapy for metastatic prostate cancer
    Shukurov, Razim
    Veliyev, Mirsaleh
    Dadashov, Zamil
    Isayev, Jeyhun
    Novruzov, Fuad
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [37] Preliminary efficacy and safety results from the (TATCIST) trial: A PSMA-directed targeted alpha therapy with FPI-2265 (225Ac-PSMA-I&T) for the treatment of metastatic castration-resistant prostate cancer (mCRPC)
    Delpassand, Ebrahim S.
    Hashmi, Mohammad Jawed
    Kazakin, Julia
    Nawaz, Omer
    Garufi, Gabriella
    Schindler, Joanne
    Nordquist, Luke
    CANCER RESEARCH, 2024, 84 (07)
  • [38] Improved safety and efficacy of 213Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with l-lysine
    Ho Sze Chan
    Mark W. Konijnenberg
    Tamara Daniels
    Monique Nysus
    Mehran Makvandi
    Erik de Blois
    Wouter A. Breeman
    Robert W. Atcher
    Marion de Jong
    Jeffrey P. Norenberg
    EJNMMI Research, 6
  • [39] Improved safety and efficacy of 213Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with L-lysine
    Chan, Ho Sze
    Konijnenberg, Mark W.
    Daniels, Tamara
    Nysus, Monique
    Makvandi, Mehran
    de Blois, Erik
    Breeman, Wouter A.
    Atcher, Robert W.
    de Jong, Marion
    Norenberg, Jeffrey P.
    EJNMMI RESEARCH, 2016, 6
  • [40] Safety, tolerability and efficacy of 212Pb-DOTAMTATE as a targeted alpha therapy for subjects with unresectable or metastatic somatostatin receptor-expressing gastroenteropancreatic neuroendocrine tumors (SSTR plus GEP-NETs): A phase 2 study
    Strosberg, Jonathan R.
    Naqvi, Shagufta
    Cohn, Allen Lee
    Delpassand, Ebrahim
    Wagner, Volker Jean
    Torgue, Julien
    Woloski, Rachel
    Manuel, Allison
    Maluccio, Mary Alice
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)